PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

Domino Printing Sciences appoints Lutz Doehnert as Group Research & Development Director to Build on Commitment to Delivering Industry-First Coding and Marking Solutions

Lutz Doehnert

Domino Printing Sciences is pleased to announce the appointment of Lutz Doehnert as the company’s Group Research & Development Director. In his new position, Lutz will lead the Global Research and Development team while continuing to build on Domino’s innovative technology, software and coding solutions.
Lutz has a proven track record of innovation and leadership in multi-national, manufacturing technology industries. He joins Domino from German high-end domestic appliance and commercial equipment manufacturer, Miele, where he was employed as Director of Research and Development. Lutz also has spent time at biotech product developer, Thermo Fisher Scientific, in the role of European Research & Development Director before becoming Global Research & Development Director.
Hilary Wright, Group HR Director at Domino says: “We are delighted to welcome Lutz on board. Together with helping our customers to do more and leveraging Domino’s innovative technology, with our Industry 4.0 enabled software and coding solutions, our focus is to serve the needs of some of the world’s most recognised global companies and help them to achieve improved production and brand protection. As the risk and pressure on our market-leading customers intensifies through increased compliance regulation it is imperative that Domino continues to provide risk mitigation through the development of products and services which meet evolving customer challenges.  With a proven track record of innovation, Lutz will be a key asset in helping us achieve this strategy.”

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026